Creative agency Terri & Sandy help fight opioid epidemic with pro-bono work
The shop has created a drive with the Partnership for Drug-Free Kids.
Opioids
Purdue Pharma reaches first opioid-related lawsuit settlement
Purdue is settling a lawsuit brought by Oklahoma for $270 million. It is facing more than 1,600 lawsuits nationwide.
Reports: Purdue weighs Chapter 11
The drugmaker is facing thousands of lawsuits saying the company contributed to the opioid crisis.
Study: Marketing opioids to doctors tied to increased overdose deaths
Researchers looked at the connections between the amount of marketing to doctors and opioid overdose deaths in a study published in JAMA.
Five things for pharma marketers to know: Wednesday, September 12, 2018
FDA threatens to ban flavored vapes; Cigna launches $250 million venture fund; Takeda shutters Chicago operations.
Purdue’s sales force targeted high prescribers with a ‘false narrative,’ unsealed lawsuit says
Directing its reps to call on GPs with little to no opioid experience, Purdue introduced aggressive promotional tactics into the prescription opioid marketing playbook.
Five things for pharma marketers to know: Tuesday, January 23, 2018
FDA issues new policies for compounded drugs; U.S. doctors test CRISPR on cancer patients for the first time; Palio merged into GSW
Five things for pharma marketers to know: Monday, January 22, 2018
Sanofi to buy Bioverativ for $11.6 billion; Celgene to acquire Juno for $9 billion; Teva to lay off more than 200 in Philadelphia
Five things for pharma marketers to know: Thursday, January 18, 2018
Senate committee votes in favor of Azar as new HHS head; FDA and DoD launch breakthrough designation program; Walmart offers free opioid disposal solution
Five things for pharma marketers to know: Thursday, January 11, 2018
Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations
